ASLAN Pharmaceuticals Ltd Sample Contracts

ASLAN Pharmaceuticals Ltd – AMENDMENT AGREEMENT No. 1 TO LICENCE AGREEMENT BETWEEN CSL LIMITED ABN 99 051 588 348 AND ASLAN Pharmaceuticals Pte Ltd (January 9th, 2019)
ASLAN Pharmaceuticals Ltd – INDEMNITY AGREEMENT (April 16th, 2018)

THIS INDEMNITY AGREEMENT (this “Agreement”) dated as of                        , 2018, is made by and between                                , an exempted company incorporated in the Cayman Islands (the “Company”), and                             (“Indemnitee”).

ASLAN Pharmaceuticals Ltd – LICENCE AGREEMENT BETWEEN CSL LIMITED ABN 99 051 588 348 AND ASLAN Pharmaceuticals Pte Ltd (March 26th, 2018)
ASLAN Pharmaceuticals Ltd – ASLAN PHARMACEUTICALS LIMITED 2017 Employee Share Option Plan 1 (March 26th, 2018)
ASLAN Pharmaceuticals Ltd – ASLAN PHARMACEUTICALS LIMITED 2014 EMPLOYEE SHARE OPTION SCHEME PLAN (March 26th, 2018)
ASLAN Pharmaceuticals Ltd – DATED THIS 10th DAY OF OCTOBER 2016 Between NANYANG TECHNOLOGICAL UNIVERSITY And ASLAN PHARMACEUTICALS PTE LTD LICENSING AND RESEARCH COLLABORATION AGREEMENT (March 26th, 2018)
ASLAN Pharmaceuticals Ltd – LICENSE AGREEMENT (March 26th, 2018)

This License Agreement (this “Agreement”), entered into as of January 3rd, 2018 (the “Effective Date”), is made by and between Array BioPharma Inc., a Delaware corporation, having offices at 3200 Walnut Street, Boulder, Colorado 80301, and ASLAN Pharmaceuticals Pte. Ltd., a Singapore corporation, with offices at 83 Clemenceau Avenue #12-03 UE Square, Singapore 239920.

ASLAN Pharmaceuticals Ltd – ASLAN PHARMACEUTICALS PTE. LTD. 2017 SMT LONG TERM INCENTIVE PLAN (March 26th, 2018)
ASLAN Pharmaceuticals Ltd – AMENDED DEVELOPMENT AND LICENSE AGREEMENT By and between ALMIRALL, S.A. and ASLAN PHARMACEUTICALS PTE. LTD. Dated: December 21, 2015 (March 26th, 2018)

This AMENDED DEVELOPMENT AND LICENSE AGREEMENT (the “Agreement”), dated as of December 21, 2015 (“Effective Date”), is entered by and between ALMIRALL, S.A. (“ALMIRALL”), a Spanish corporation having its principal offices at Ronda de General Mitre, 151, 08022 Barcelona, Spain, and ASLAN PHARMACEUTICALS Pte. Ltd. (“ASLAN”), a Singapore corporation having its principal offices at 10A Bukit Pasoh Road, Singapore 089824. ALMIRALL and ASLAN shall be referred to individually as a “Party” and collectively as the “Parties”.

ASLAN Pharmaceuticals Ltd – Stamp Certificate Reference : 213013-01LA3-1-343962116 Stamp Certificate Issued Date : 20/07/2016 Applicant’s Reference : SES.NSA.KW00800.0159 Document Reference Number : 2016062801095 ver. 1.0 Document Description : Acceptance to Offer of Lease (Ad valorem) Date of Document : 15/07/2016 Property : 83 CLEMENCEAU AVENUE, #12-03, SINGAPORE 239920 Lessor/ Landlord : UNITED ENGINEERS LIMITED (UEN-LOCALCO -191200018G) Lessee/ Tenant : ASLAN PHARMACEUTICALS PTE. LTD. (UEN-LOCALCO - 201007695N) Stamp Duty : S$ 4,536.00 Total Amount : S$ 4,536.00 (March 26th, 2018)
ASLAN Pharmaceuticals Ltd – LICENSE AGREEMENT (February 27th, 2018)

This License Agreement (this “Agreement”), entered into as of January 3rd, 2018 (the “Effective Date”), is made by and between Array BioPharma Inc., a Delaware corporation, having offices at 3200 Walnut Street, Boulder, Colorado 80301, and ASLAN Pharmaceuticals Pte. Ltd., a Singapore corporation, with offices at 83 Clemenceau Avenue #12-03 UE Square, Singapore 239920.

ASLAN Pharmaceuticals Ltd – LICENCE AGREEMENT BETWEEN CSL LIMITED ABN 99 051 588 348 AND ASLAN Pharmaceuticals Pte Ltd (February 27th, 2018)
ASLAN Pharmaceuticals Ltd – AMENDED DEVELOPMENT AND LICENSE AGREEMENT By and between ALMIRALL, S.A. and ASLAN PHARMACEUTICALS PTE. LTD. Dated: December 21, 2015 (February 27th, 2018)

This AMENDED DEVELOPMENT AND LICENSE AGREEMENT (the “Agreement”), dated as of December 21, 2015 (“Effective Date”), is entered by and between ALMIRALL, S.A. (“ALMIRALL”), a Spanish corporation having its principal offices at Ronda de General Mitre, 151, 08022 Barcelona, Spain, and ASLAN PHARMACEUTICALS Pte. Ltd. (“ASLAN”), a Singapore corporation having its principal offices at 10A Bukit Pasoh Road, Singapore 089824. ALMIRALL and ASLAN shall be referred to individually as a “Party” and collectively as the “Parties”.

ASLAN Pharmaceuticals Ltd – DATED THIS 10th DAY OF OCTOBER 2016 Between NANYANG TECHNOLOGICAL UNIVERSITY And ASLAN PHARMACEUTICALS PTE LTD LICENSING AND RESEARCH COLLABORATION AGREEMENT (February 27th, 2018)
ASLAN Pharmaceuticals Ltd – ASLAN PHARMACEUTICALS LIMITED 2017 Employee Share Option Plan 1 (December 20th, 2017)
ASLAN Pharmaceuticals Ltd – ASLAN PHARMACEUTICALS LIMITED 2014 EMPLOYEE SHARE OPTION SCHEME PLAN (December 20th, 2017)
ASLAN Pharmaceuticals Ltd – ASLAN PHARMACEUTICALS PTE. LTD. 2017 SMT LONG TERM INCENTIVE PLAN (December 20th, 2017)
ASLAN Pharmaceuticals Ltd – Stamp Certificate Reference : 213013-01LA3-1-343962116 Stamp Certificate Issued Date : 20/07/2016 Applicant’s Reference : SES.NSA.KW00800.0159 Document Reference Number : 2016062801095 ver. 1.0 Document Description : Acceptance to Offer of Lease (Ad valorem) Date of Document : 15/07/2016 Property : 83 CLEMENCEAU AVENUE, #12-03, SINGAPORE 239920 Lessor/ Landlord : UNITED ENGINEERS LIMITED (UEN-LOCALCO -191200018G) Lessee/ Tenant : ASLAN PHARMACEUTICALS PTE. LTD. (UEN-LOCALCO - 201007695N) Stamp Duty : S$ 4,536.00 Total Amount : S$ 4,536.00 (December 20th, 2017)
ASLAN Pharmaceuticals Ltd – AMENDED DEVELOPMENT AND LICENSE AGREEMENT By and between ALMIRALL, S.A. and ASLAN PHARMACEUTICALS PTE. LTD. Dated: December 21, 2015 (December 20th, 2017)

This AMENDED DEVELOPMENT AND LICENSE AGREEMENT (the “Agreement”), dated as of December 21, 2015 (“Effective Date”), is entered by and between ALMIRALL, S.A. (“ALMIRALL”), a Spanish corporation having its principal offices at Ronda de General Mitre, 151, 08022 Barcelona, Spain, and ASLAN PHARMACEUTICALS Pte. Ltd. (“ASLAN”), a Singapore corporation having its principal offices at 10A Bukit Pasoh Road, Singapore 089824. ALMIRALL and ASLAN shall be referred to individually as a “Party” and collectively as the “Parties”.

ASLAN Pharmaceuticals Ltd – DATED THIS 10th DAY OF OCTOBER 2016 Between NANYANG TECHNOLOGICAL UNIVERSITY And ASLAN PHARMACEUTICALS PTE LTD LICENSING AND RESEARCH COLLABORATION AGREEMENT (December 20th, 2017)